|Title:||Serum brain-derived neurotrophic factor (BDNF) and its association with remission status in Chinese patients with schizophrenia|
|Alternate Journal:||Psychiatry research|
|Abstract:||The neurotrophin, brain-derived neurotrophic factor (BDNF), characterises a probable neurobiochemical explanation of maldevelopments in schizophrenia and is a candidate biomarker of the illness. A paucity of studies examining neurobiochemical predictors of remission in schizophrenia exists. In this study, we seek to examine if serum BDNF level is associated with remission status in a sample of Chinese patients with schizophrenia. This study did not find a significant relationship between serum BDNF and remission in patients with schizophrenia. Identification of a suitable biomarker for diagnosis, management, and prognostic outcome is crucial and warrants further study.|
Research Support, Non-U.S. Gov't
Psychiatry Res. 2014 Dec 15
220(1-2):193-6. doi: 10.1016/j.psychres.2014.07.079. Epub 2014 Aug 12.
|Authors Address:||Research Division, Institute of Mental Health, Singapore.|
Research Division, Institute of Mental Health, Singapore
Department of General Psychiatry 1, Institute of Mental Health, Singapore
Office of Clinical Sciences, Duke-NUS Graduate Medical School, Singapore. Electronic address: firstname.lastname@example.org.
|Appears in Collections:||2014|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
Using Fade OutX